Denis Lambrigts is a seasoned professional in the field of quality control and innovation for vaccines, currently serving as the Head of Vaccines Global Quality Control and Innovation at GSK since May 2004. Throughout Denis Lambrigts' career at GSK, notable leadership roles included overseeing Global Analytical Science and Technology, as well as Animal Welfare and Ethics within the 3Rs program. Denis has extensive experience in managing biochemistry and in vivo laboratories for the release of commercial vaccines, and has directed large teams of veterinarians, engineers, biologists, and technicians in various quality control capacities. Prior roles included Senior Manager of Biochemistry and In Vivo Quality Control at GSK and Head of In Vivo at UCB. Educational qualifications consist of being a Diplomate of the European College of Laboratory Animal Medicine, alongside a Doctorate in Veterinary Medicine from the University of Liège.